MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1007/s00104-020-01197-5

Медицинская библиотека · Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen · 2021

[Surgical treatment of primary sclerosing cholangitis : Experiences from 30 years in a single center cohort with 173 consecutive patients].

Branchi Vittorio, Weismüller Tobias J, Zhou Taotao, Henn Jonas, Semaan Alexander, Glowka Tim R, Gonzalez-Carmona Maria, Strassburg Christian, Kalff Jörg C, Manekeller Steffen, Matthaei Hanno

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

In recent years substantial progress has been made in the treatment, surveillance and understanding of the pathogenesis of primary sclerosing cholangitis (PSC); however, in most cases liver transplantation (LTX) is still the only curative option for cancer or end-stage liver disease (ELD). In rare cases a partial liver resection is a possible curative treatment of a PSC-associated cholangiocellular carcinoma (CCC). These operations represent a significant additional burden for PSC patients.

OBJECTIVE

Due to the rarity of PSC detailed studies regarding hepato-pancreato-biliary (HPB) surgery are lacking. The aim of this study was to analyze the surgical indications and prognosis of PSC patients.

PATIENTS AND

METHODS

A single center retrospective cohort study from 1990 to 2020 was carried out. In this study patients with PSC were included and investigated with respect to factors associated with surgery and the prognosis.

RESULTS

As a consequence of PSC-associated conditions, in 62 patients (36%) a major HPB operation or explorative laparotomy was necessary. The prevalence of chronic inflammatory bowel disease was significantly higher in these patients (P < 0.019). An LTX was carried out in 46 patients (73%) because of ELD. A liver resection (LR) was performed in 8 patients (11%) and 9 patients only underwent an explorative laparotomy. The overall survival in the LTX subgroup was significantly longer than patients who underwent LR and explorative laparotomy (258 months; 95% confidence interval, CI 210-306 months vs. 88 months; 95% CI 16-161 months vs. 13 months; 95% CI 3-23 months; p < 0.05, respectively).

CONCLUSION

The majority of patients with PSC have to be operated on because of the disease with substantial risks for morbidity and mortality. Curative treatment options are lacking, thus underlining the need for effective early detection and treatment strategies for PSC-CCC.

Для цитирования: Branchi Vittorio, Weismüller Tobias J, Zhou Taotao, Henn Jonas, Semaan Alexander, Glowka Tim R, Gonzalez-Carmona Maria, Strassburg Christian, Kalff Jörg C, Manekeller Steffen, Matthaei Hanno. [Surgical treatment of primary sclerosing cholangitis : Experiences from 30 years in a single center cohort with 173 consecutive patients].. Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen. 2021. DOI: 10.1007/s00104-020-01197-5.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.